On September 25th, the National Medical Products Administration announced that it has recently approved the registration application for the innovative product "CT angiography image assisted detection software for intracranial aneurysms" of Shanghai Lianying Intelligent Medical Technology Co., Ltd. (hereinafter referred to as "Lianying Intelligent").

Effective improvement, innovative products begin to emerge
Lianying Intelligence is an artificial intelligence company under Lianying Group, established in Shanghai at the end of 2017. It is an important strategic layout of Lianying Group in the field of artificial intelligence. Relying on the high-performance software and hardware technology platform and resource advantages of Lianying Group, Lianying Intelligence has become a medical AI enterprise that can provide multi scenario, multi disease, full process, and integrated intelligent solutions. It empowers clinical, scientific research, and equipment with AI, covering multiple AI application scenarios such as hospital level management, medical innovation ecology, workflow optimization, precision diagnosis and treatment, and personal health management. With high-end full dimensional medical AI innovation, it promotes the unity of life and health.

As of now, Lianying Intelligence has completed the research and development of dozens of AI applications, which have been implemented in more than a thousand hospitals across the country and run through the entire diagnosis and treatment process; Undertook and participated in over 80 national, provincial, and local science and technology projects; Accumulated publication of nearly 400+scientific research papers.

It is understood that this intracranial aneurysm CT angiography image assisted detection software consists of software installation programs and authorization files. The functional modules include browser and server, which are used for displaying, processing, measuring, and analyzing head and neck artery CT angiography images. It can assist in the detection of intracranial aneurysms of 3mm or more.

Moreover, the product adopts deep learning based head and neck vessel segmentation technology and multi-scale aneurysm detection technology, effectively improving the diagnostic accuracy and efficiency of intracranial aneurysms, which is of great significance for improving patient survival rate.

According to the Medicine Intelligence Medical Device Database, in addition to the CT angiography image assisted detection software for intracranial aneurysms developed by Lianying Intelligence, there are three similar products already on the market in China, namely the CT angiography image assisted triage software for intracranial aneurysms developed by Tuxiang Medical; Shenrui Medical's intracranial aneurysm CT angiography image assisted detection software; Yukun Technology's intracranial aneurysm CT angiography image assisted triage software.

From the perspective of approval time, several products have a short interval and are all recently launched products. Now that Lianying Intelligent's products of this type have been approved for market, it will bring good news to the diagnosis of intracranial aneurysms.

Focusing on AI and achieving multiple innovative results
As a layout of Lianying Group in the field of AI, Lianying Intelligence has achieved multiple innovative results in recent years.

On April 11th, at the 89th China International Medical Equipment (Spring) Expo, Lianying Intelligent showcased its heavyweight uAI intelligent model, over 100 AI applications, and more than 10 AI solutions.

It is understood that through extensive data training, the uAI Shadow Intelligence Big Model has universal low-level learning skills for medical imaging and the ability to quickly transfer to new disease types. It can fully utilize the correlation between different modalities and tasks, and achieve excellent performance for various tasks. Taking the task of renal artery vessel segmentation as an example, after testing, this large model only requires 10 training data to achieve the performance level that traditional small models need to use 201 data to achieve.

For the future vision of large models in clinical practice, Lianying Intelligence has further proposed the uAI NEXUS integrated platform. UAI NEXUS will become a comprehensive entity that integrates algorithm models, data, and computing power. It not only has global, interconnected, and collective intelligent decision-making capabilities, but also can achieve self-learning and evolution, achieving the ultimate form of medical AI big models.

In addition, Lianying Intelligence has also launched more than 10 AI innovative solutions. Among them, Lianying Intelligence has launched two new products: intelligent analysis of brain function and intelligent analysis of brain fibers. Combined with the existing intelligent analysis system of brain structure, Lianying Intelligence has formed a full ecological layout of brain science research scenarios for brain function, brain fibers, and brain structure, suitable for brain research of all ages from 0 to 90.

In terms of the heart, Lianying Intelligence has launched the first one-stop AI solution for cardiac magnetic resonance imaging covering multiple sequences in China, supporting cardiac function, cardiac strain T1 Mapping、LGE/T2W、 A series of quantitative evaluations and analyses of multiple sequences such as perfusion.

Source: https://news.yaozh.com/archive/44274.html